INVO Fertility (NASDAQ:IVF) Announces Quarterly Earnings Results

INVO Fertility (NASDAQ:IVFGet Free Report) posted its quarterly earnings results on Tuesday. The company reported ($12.53) earnings per share (EPS) for the quarter, Zacks reports.

INVO Fertility Price Performance

IVF traded up $0.01 on Tuesday, hitting $2.18. 390,931 shares of the company were exchanged, compared to its average volume of 1,465,536. INVO Fertility has a 12 month low of $1.38 and a 12 month high of $17.04. The firm has a market cap of $2.32 million, a price-to-earnings ratio of -0.08 and a beta of 2.24.

About INVO Fertility

(Get Free Report)

NAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues.

Featured Articles

Receive News & Ratings for INVO Fertility Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Fertility and related companies with MarketBeat.com's FREE daily email newsletter.